RAPT Therapeutics Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Rapt Therapeutics, Inc. |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
RAPT Therapeutics filed its Q1 2025 10-Q, showing R&D spend and stock options.
AI Summary
RAPT Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance, including research and development expenses and share-based compensation. It also notes the company's former name, FLX Bio, Inc., and its name change date of May 4, 2016.
Why It Matters
This filing provides investors with an update on RAPT Therapeutics' financial health and operational activities for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a clinical-stage biopharmaceutical company, RAPT Therapeutics faces inherent risks related to drug development and regulatory approvals.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of 2025)
- 2025-01-01 to 2025-03-31 — Financial Period (Specific dates for financial reporting in Q1 2025)
Key Players & Entities
- RAPT Therapeutics, Inc. (company) — Filer
- FLX Bio, Inc. (company) — Former company name
- 20250331 (date) — Reporting period end date
- 20250508 (date) — Filing date
- 561 ECCLES AVENUE (address) — Business and mailing address
- SOUTH SAN FRANCISCO, CA (address) — Business and mailing city/state
- 94080 (zip_code) — Business and mailing zip code
- 473313701 (ein) — Employer Identification Number
FAQ
What was the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing was March 31, 2025.
What was RAPT Therapeutics, Inc. formerly known as?
RAPT Therapeutics, Inc. was formerly known as FLX Bio, Inc.
When did the company change its name from FLX Bio, Inc.?
The company changed its name from FLX Bio, Inc. on May 4, 2016.
What is the business address of RAPT Therapeutics, Inc.?
The business address is 561 Eccles Avenue, South San Francisco, CA 94080.
What is the SIC code for RAPT Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code is 2834, Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding RAPT Therapeutics, Inc..